Novo Nordisk forges close ties with biotech VC Flagship
pharmaphorum
MAY 11, 2022
That was the thinking applied to the formation of Moderna, which paid off spectacularly with its COVID-19 vaccine, used around the world to fight the pandemic, as well as its rapidly expanding pipeline of additional therapeutics. The move follows Novo Nordisk’s $3.3
Let's personalize your content